Your browser is no longer supported. Please, upgrade your browser.
Settings
VAPO Vapotherm, Inc. daily Stock Chart
VAPO [NYSE]
Vapotherm, Inc.
Index- P/E- EPS (ttm)-2.32 Insider Own38.60% Shs Outstand17.63M Perf Week-3.60%
Market Cap288.07M Forward P/E- EPS next Y-2.68 Insider Trans- Shs Float9.83M Perf Month-9.87%
Income-38.60M PEG- EPS next Q-1.27 Inst Own51.90% Short Float2.21% Perf Quarter-
Sales41.10M P/S7.01 EPS this Y-34.40% Inst Trans25.57% Short Ratio1.85 Perf Half Y-
Book/sh-190.35 P/B- EPS next Y61.20% ROA- Target Price24.67 Perf Year-
Cash/sh0.75 P/C21.82 EPS next 5Y- ROE- 52W Range14.70 - 22.07 Perf YTD-18.10%
Dividend- P/FCF- EPS past 5Y- ROI27.50% 52W High-25.96% Beta-
Dividend %- Quick Ratio1.90 Sales past 5Y- Gross Margin37.50% 52W Low11.16% ATR1.17
Employees298 Current Ratio3.00 Sales Q/Q19.00% Oper. Margin-85.10% RSI (14)44.69 Volatility5.42% 6.85%
OptionableNo Debt/Eq- EPS Q/Q-23.50% Profit Margin-94.00% Rel Volume0.36 Prev Close16.45
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume118.01K Price16.34
Recom1.00 SMA20-5.77% SMA50-8.25% SMA200-8.25% Volume41,925 Change-0.67%
Dec-10-18Initiated William Blair Outperform
Dec-10-18Initiated Canaccord Genuity Buy $25
Dec-10-18Initiated BofA/Merrill Buy $26
Dec-24-18 07:30AM  Vapotherm to be Added to the Russell 2000®, 3000® and Microcap® Indexes Business Wire
Dec-04-18 08:00AM  Clinical Study Shows Vapotherms New IntellO2 Module for Precision Flow® System Significantly Improves Maintenance of Premature Neonates in Target Oxygenation Range Business Wire
Nov-16-18 11:58AM  Vapotherm Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Nov-14-18 11:08AM  Vapotherm shares soar 8.5% in trading debut MarketWatch
06:58AM  Vapotherm sells 4 million shares priced at $14 each in IPO to raise $56 million MarketWatch
Nov-13-18 08:48PM  Vapotherm Announces Pricing of Initial Public Offering Business Wire
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals through a direct sales force in the United States; and through distributors in various countries internationally. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.